Of all the chronic illness presentations that functional medicine practitioners encounter, mold illness and mycotoxin toxicity are among the most misunderstood and most debilitating. People with significant mycotoxin burden often spend years — sometimes decades — cycling through presentations of fibromyalgia, chronic fatigue syndrome, depression, anxiety, autoimmune disease, and hormonal dysfunction, never knowing that the root cause of their suffering is a class of fungal toxins that their body cannot clear on its own.
Mycotoxins are not simply an allergy or a sensitivity. They are potent biological toxins produced by mold species — primarily Aspergillus, Fusarium, Stachybotrys, Penicillium, and Trichothecium — that damage mitochondria, disrupt the immune system, cross the blood-brain barrier, suppress hormone production, and accumulate in tissues throughout the body. They are fat-soluble, which means they are stored in cell membranes, the brain, and fatty tissues, and they do not clear on their own without targeted intervention.
The Advanced Mycotoxin Support Protocol is a comprehensive program available for addressing mycotoxin burden, biotoxin illness, and the complex web of co-conditions — including Lyme disease, co-infections, and chemical toxicity — that so often accompany mold exposure. It is not a simple cleanse. It is a systematic, phased approach to clearing some of the most difficult-to-remove toxins the human body encounters.
Dealing with mold illness, unexplained chronic symptoms, or biotoxin burden?
The Advanced Mycotoxin Support Protocol is a targeted program for mycotoxin clearance and biotoxin illness recovery.
Understanding Mycotoxin Illness: Why It Is So Difficult to Identify and Address
Mycotoxin illness — also called Chronic Inflammatory Response Syndrome (CIRS) when it involves a broader biotoxin response — is characterized by a specific pattern of immune dysregulation. In genetically susceptible individuals (approximately 25% of the population carries the HLA-DR gene variants that impair biotoxin clearance), the innate immune system cannot properly identify and tag mycotoxins for elimination. Instead of clearing them, the body mounts a chronic, low-grade inflammatory response that affects virtually every organ system.
The symptoms of mycotoxin illness are notoriously non-specific: fatigue that does not improve with rest, cognitive impairment and memory problems, muscle pain and weakness, hormonal disruption, digestive dysfunction, recurrent infections, chemical sensitivities, and mood disorders. Because these symptoms overlap with so many other conditions, and because conventional laboratory testing does not routinely screen for mycotoxins, most patients are never correctly identified.
Dr. Richie Shoemaker’s decades of research on CIRS, Dr. Neil Nathan’s clinical work with mold-injured patients, and Dr. Jill Carnahan’s own personal recovery from mold illness have collectively established that mycotoxin burden is far more prevalent than conventional medicine acknowledges — and that it requires a specific, targeted approach to resolve.
Why Standard Detox Protocols Are Not Enough for Mycotoxin Illness
Most detox protocols — even good ones — are not designed for the specific challenges of mycotoxin clearance. Mycotoxins are fat-soluble and tissue-stored, which means water-soluble binders like activated charcoal or bentonite clay have limited effectiveness against them. They are also recirculated through the enterohepatic circulation: the liver packages them into bile, releases them into the small intestine, and if an adequate binder is not present to capture them, they get reabsorbed and returned to circulation. This cycle can continue indefinitely without targeted intervention.
Additionally, mycotoxins frequently co-exist with other biotoxins — Lyme spirochetes, Babesia, Bartonella, heavy metals, and chemical toxins — that must be addressed in the correct sequence. Attempting to clear mycotoxins without first addressing drainage, mitochondrial function, and the underlying pathogen burden that often accompanies mold illness leads to incomplete clearance and persistent symptoms.
The Advanced Mycotoxin Support Protocol is built around these specific challenges. Its formulas are selected for their ability to bind fat-soluble mycotoxins, support the liver’s bile production and flow, cross the blood-brain barrier to reach neurologically stored toxins, and address the immune dysregulation that perpetuates the chronic inflammatory response.
The Role of Carbon Technology in Mycotoxin Clearance
What makes This approach to mycotoxin clearance categorically different from conventional protocols is Carbon Technology — the humic and fulvic acid delivery system that underlies every formula in the Mycotoxin Support Protocol.
Humic and fulvic acids are naturally occurring compounds produced by the decomposition of ancient organic matter. At the nanoparticle scale used in the formulas in this protocol, they have several properties that are uniquely suited to mycotoxin clearance. First, they are fat-soluble enough to penetrate cell membranes and reach toxins stored in tissues — including the brain. Second, they have a high electron potential and low pH that allows them to bind and neutralize mycotoxins through a chelation-like mechanism. Third, they are small enough to cross the blood-brain barrier, which is critical for clearing the neurological mycotoxin burden that drives so many of the cognitive and mood symptoms of mold illness.
Conventional binders cannot do this. Cholestyramine — the pharmaceutical binder most commonly used in CIRS protocols — works only in the gut. It cannot reach the mycotoxins stored in the brain, the liver, the kidneys, or the fatty tissues. Carbon Technology can.
What Is in the Advanced Mycotoxin Support Protocol
The Advanced Mycotoxin Support Protocol is a multi-formula, phased program that addresses mycotoxin burden systematically — from drainage and energy support through targeted binding, immune modulation, and systemic clearance.
Foundation Formulas: Drainage & Energy
Like all these protocols, the Mycotoxin Support Protocol begins with the foundational drainage and energy support formulas: BC-ATP (mitochondrial energy and gentle binder), CT-Minerals (bioavailable fulvic acid minerals), and KL Support (kidney and liver drainage). These are not optional additions — they are prerequisites. Mycotoxin clearance generates significant metabolic load on the liver and kidneys. Without adequate drainage support, the mobilized toxins have nowhere to go and symptoms worsen.
BioToxin Binder: The Primary Mycotoxin Binder
BioToxin Binder is the primary binding agent in the Mycotoxin Support Protocol. Its Carbon Technology base has been specifically validated for mycotoxin binding — including ochratoxin A, aflatoxins, trichothecenes, and zearalenone — the most clinically significant mycotoxins associated with water-damaged building exposure. It interrupts the enterohepatic recirculation of mycotoxins, preventing reabsorption and supporting their elimination through the stool.
ViRadChem Binder: Viral, Radioactive & Chemical Clearance
ViRadChem Binder addresses the viral, radioactive, and chemical toxin burden that frequently co-exists with mycotoxin illness. People with significant mold exposure often have concurrent viral reactivation (Epstein-Barr, HHV-6, cytomegalovirus), chemical sensitivity, and environmental toxin accumulation. ViRadChem’s Carbon Technology targets these compounds specifically, providing a broader clearance spectrum than BioToxin Binder alone.
Advanced TUDCA: Bile Flow & Liver Protection
Advanced TUDCA (tauroursodeoxycholic acid) is one of the most important additions to any mycotoxin protocol. TUDCA is a bile acid that stimulates bile flow, protects liver cells from the oxidative damage caused by mycotoxin processing, and supports the gut-liver axis that is central to mycotoxin elimination. Without adequate bile flow, fat-soluble mycotoxins cannot be effectively packaged and eliminated. TUDCA ensures that the liver’s mycotoxin processing capacity is fully supported throughout the protocol.
LymphActiv: Lymphatic Drainage for Systemic Clearance
LymphActiv supports the lymphatic system — the network of vessels that drains cellular waste from tissues throughout the body. In mold illness, the lymphatics are often severely congested: mycotoxins, immune complexes, and inflammatory debris accumulate in lymph nodes and tissues, contributing to the widespread pain, swelling, and fatigue that characterize the condition. LymphActiv’s botanical formula (astragalus, burdock root, cleavers, red clover, and sheep sorrel) supports lymphatic flow and drainage, helping the body clear the systemic mycotoxin burden that extends beyond the gut.
Comprehensive mycotoxin clearance using Carbon Technology — reaching the brain, cells, and tissues that conventional binders cannot.
Who Is the Advanced Mycotoxin Support Protocol For?
The Advanced Mycotoxin Support Protocol is a good fit for anyone with confirmed or suspected mycotoxin burden — particularly those who have lived or worked in water-damaged buildings, experienced significant mold exposure, or have a history of unexplained multi-system chronic illness that has not responded to conventional support.
It is also appropriate for individuals with Lyme disease and co-infections, as mycotoxin burden and tick-borne illness frequently co-exist and mutually reinforce each other. Mycotoxins suppress the immune response that would otherwise keep Lyme in check, while Lyme-related immune dysregulation impairs the body’s ability to clear mycotoxins. Addressing both simultaneously — as the Mycotoxin Support Protocol is designed to do — produces better outcomes than addressing either in isolation.
Additional indications include: chronic fatigue syndrome, fibromyalgia, chemical sensitivities, hormonal disruption without clear cause, neurological symptoms (brain fog, memory problems, mood disorders, neuropathy), and any presentation of CIRS as defined by Dr. Richie Shoemaker’s clinical criteria.
Ready to address your mycotoxin burden at the root?
The Advanced Mycotoxin Support Protocol is the most targeted protocol for mold illness, CIRS, and biotoxin-related chronic conditions.
🌿 Recommended Tools & Resources
These are the specific supplements, labs, and services Jacob recommends in connection with the Advanced Mycotoxin Support Protocol.
From the Supplement Store
The primary mycotoxin binder in the Mycotoxin Support Protocol. Carbon Technology binds ochratoxin A, aflatoxins, trichothecenes, and other clinically significant mycotoxins — interrupting enterohepatic recirculation and supporting elimination through the gut.
View in Store →
Mitochondrial restoration is essential in mold illness — mycotoxins directly damage mitochondria and impair ATP production. BC-ATP restores cellular energy, supports gentle detox, and makes all other protocol formulas more effective.
View in Store →
Glutathione is the body’s master antioxidant and the primary defense against mycotoxin-induced oxidative damage. Quicksilver’s liposomal delivery ensures it reaches the cells and tissues — including the brain — where mycotoxin damage is most severe. Essential for anyone with significant mold burden.
View in Store →
A multi-binder combining zeolite clay, activated charcoal, silica, apple pectin, and humic acid — providing additional gut-based binding capacity alongside the CellCore binders. Particularly useful for those with significant chemical sensitivity or high mycotoxin load who need broader binding support.
View in Store →
Recommended Protocols
The most targeted protocol I use for mycotoxin burden, CIRS, and biotoxin-related chronic illness. Phased approach using Carbon Technology to clear mycotoxins from the gut, tissues, and brain.
Get the Mycotoxin Support Protocol →
Recommended Functional Lab Testing
The most comprehensive toxic burden panel available — measuring mycotoxins, heavy metals, and environmental chemicals in a single test. Essential for confirming mycotoxin burden before beginning the Mycotoxin Support Protocol and for tracking clearance progress.
Order Lab Test →
Ready for a Protocol Built Around You — Not a Fixed Kit?
Mold illness is complex — and the Advanced Mycotoxin Support Protocol is one of the most powerful tools available for addressing it. If you want to go deeper than a fixed protocol and build a personalized approach around your specific labs, history, and root causes, working one-on-one with Jacob gives you a practitioner-guided plan that adapts as your body responds. point for your recovery.
🌿 Key Takeaways
- Mycotoxins are fat-soluble, tissue-stored toxins that recirculate through bile — conventional binders cannot fully clear them
- Carbon Technology crosses the blood-brain barrier and reaches mycotoxins stored in neurological tissue
- Drainage must be open before mycotoxin clearance begins — mobilized toxins need an exit route
- Mold illness and Lyme disease frequently co-exist and must be addressed together for full recovery
- TUDCA and bile flow support are essential — the liver is the primary mycotoxin processing organ
- The Mycotoxin Support Protocol pairs powerfully with Quicksilver liposomal formulas for systemic and neurological clearance
References
- Shoemaker RC. Surviving Mold: Life in the Era of Dangerous Buildings. Otter Bay Books; 2010.
- Nathan N. Toxic: Heal Your Body from Mold Toxicity, Lyme Disease, Multiple Chemical Sensitivities, and Chronic Environmental Illness. Victory Belt Publishing; 2018.
- Carnahan J. Unexpected: Finding Resilience through Functional Medicine, Science, and Faith. Hay House; 2023.
- Pizzorno J. The Toxin Solution. HarperOne; 2017.
- Bennett JW, Klich M. Mycotoxins. Clinical Microbiology Reviews. 2003;16(3):497–516.
- Brewer JH, et al. Detection of mycotoxins in patients with chronic fatigue syndrome. Toxins. 2013;5(4):605–617.
- Thrasher JD, Crawley S. The biocontaminants and complexity of damp indoor spaces: more than meets the eyes. Toxicology and Industrial Health. 2009;25(9–10):583–615.
- Sears ME, Genuis SJ. Environmental determinants of chronic disease and medical approaches. Journal of Environmental and Public Health. 2012;2012:356798.
- Bjørklund G, et al. Fulvic acid and humic acid: health effects and mechanisms. Journal of Molecular Sciences. 2018;19(8):2446.
- Shade C. The Detox Paradox: Why Mobilizing Toxins Without Open Drainage Causes Harm. Quicksilver Scientific; 2019.
- Vibrant Wellness. MycoTOX Profile Test Methodology. Vibrant America; 2023.
- CellCore Biosciences. Practitioner FAQ and Product Reference Guide. Internal practitioner document; 2024.
- Bredesen DE. The End of Alzheimer’s. Avery; 2017.
- Levy T. Hidden Epidemic. MedFox Publishing; 2017.
